首页> 外国专利> New quaternised 1,1-di:cycloalkyl-4-amino-2-butyn-1-ol derivs. - are cholinergic muscarinic receptor blockers, useful for treating chronic obstructive airways disease and asthma

New quaternised 1,1-di:cycloalkyl-4-amino-2-butyn-1-ol derivs. - are cholinergic muscarinic receptor blockers, useful for treating chronic obstructive airways disease and asthma

机译:新的季铵化的1,1-二:环烷基-4-氨基-2-丁炔-1-醇衍生物。 -是胆碱能毒蕈碱受体阻滞剂,可用于治疗慢性阻塞性气道疾病和哮喘

摘要

Quaternised 1,1-dicycloalkyl-4-amino -2-butyn-1-ols of formula (I) are new. R1, R2 = cyclohexyl or cyclopentyl substd by 1 1-4C alkyl, 1-4C hydroxyalkyl or 1-4C haloalkyl gps. R3, R4 = 1-6C alkyl, or together form a 5-7 membered ring, which may contain extra 0 or S heteroatoms or be substd by 1-4C alkyl. R5 = CH3 or CH2CH3. X' an anion. Also claimed is a method for preparing (I) from a ketone of formula R1C0R2 and a cpd of formula M-CC-CH2-NR3R4, where M is a reactive metal. The resulting intermediate is hydrolysed and reacted with a cpd of formula R5X. (I) is eg 1,1-dicyclohexyl-4-piperidino -2-butyn-1-ol-methoiodide.
机译:式(I)的季铵化的1,1-二环烷基-4-氨基-2-丁炔-1-醇是新的。 R 1,R 2 =环己基或环戊基,由1 1-4C烷基,1-4C羟烷基或1-4C卤代烷基gps取代。 R 3,R 4 = 1-6C烷基,或一起形成5-7元环,其可含有额外的0或S杂原子或被1-4C烷基取代。 R5 = CH3或CH2CH3。 X'阴离子。还要求保护一种由式R1C0R2的酮和式M-CC-CH2-NR3R4的cpd制备(I)的方法,其中M是反应性金属。将所得的中间体水解并与式R5X的cpd反应。 (I)为例如1,1-二环己基-4-哌啶子基-2-丁炔-1-醇-甲基碘。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号